This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.

This November, our Formulation Series discussion group focused on the formulation and delivery of inhaled biologics. Oxford Global’s discussion groups bring together a select group of 15-20 key industry leaders for approximately one hour for in depth knowledge sharing and conversation.

Can Inhaled Biologics make a comeback?  

Exploring advancements in inhalation products with Peter J Barnes.

In this Insight Article, we delve into the challenges of the gastrointestinal tract for oral peptide delivery and look at 3 of the most promising solution technologies

Mark Milton-Edwards, Head Of Product & Health Solutions - Digital Health, Teva

Pavan Muttil, Associate Professor, Pharmaceutical Sciences, University of New Mexico

David Cipolla, Vice President, Insmed

Boris Shekunov, Senior Principal Scientist/Director, Takeda

Josue Sznitman, Associate Professor, Israel Institute of Technology